WO
Woodnewton
Has won 4 UK public-sector contracts worth £1.8m across 2 buyers, primarily Medicines and Healthcare Products Regulatory Agency.
Active contracts
2
no new awards in 30d
Contracted (12m)
—
▼ 100% vs prior 12m
Public buyers
2
stable this month
Top buyer share
95%
Medicines and Healthcare Products Regulatory Agency
Buyer concentration
Each block sized by share of total award value. A dominant block signals dependency on one buyer.
Severe concentration. Top buyer alone = 95% of revenue.
Medicines and Healthcare Products Regulatory Agency
£1.7m
95%NHS England
£91k
5%Contracts won · 4 total · 2 active · 2 expired
Every contract award published under the Procurement Act.
| Title | Buyer | Award type | Value | Awarded | Status |
|---|---|---|---|---|---|
| MHRA Customer & Stakeholder Insights Research (DPS CCS RM6126) 2025 | Medicines and Healthcare Products Regulatory Agency | Direct contract | £1.2m | 06 Apr 2025 | active |
| Customer and Stakeholder Insights Research - DPS Competition CCS RM6126 | Medicines and Healthcare Products Regulatory Agency | Direct contract | £530k | 06 Jun 2023 | active |
| National Overprescribing Review implementation evaluation - healthcare professional survey and insights feasibility study | NHS England | Direct contract | £47k | 10 Mar 2022 | expired |
| National Overprescribing Review implementation evaluation - patient survey and insights feasibility study | NHS England | Direct contract | £44k | 10 Mar 2022 | expired |